02/19/2026
Payment caps. WISeR utilization management. Tighter clinical evidence requirements.
Even without new LCDs, oversight on skin substitutes is increasing — and the impact on providers and health systems is real.
In our latest blog, we break down:
✔ What’s already changed
✔ What may be coming next
✔ What organizations should be doing now to stay ahead
Don’t wait for the next policy shift to react. Prepare strategically.
👉 Read the full post: https://hubs.la/Q043BKhw0